{"example_id": "0954-00", "context": "An NMP (1 mL) solution of 5'-fluoro-N-(1-methyl-3-(pyridin-2-yl)-1H-pyrazol-4-yl)-[2,3'-bipyridine]-6-carboxamide (22.5 mg, 0.06 mmol), dimethylamine hydrochloride (5 eq.) and NaHCO3 (2 eq) was heated at 120-150\u00b0 C. for 11 days until 50% of desired product was formed, as monitored by LC-MS. Solvent.", "anaphor": "Solvent", "gold_antecedents": ["NMP (1 mL)"], "preceding_anaphors": []}
{"example_id": "1464-00", "context": "Compound 45 was synthesized from macrocycle C (100 mg, 0.143 mmol), p-tolyl isocyanate (19.1 mg, 0.143 mmol) and triethylamine (78 \u03bcL, 0.574 mmol) as a white solid (30 mg, 26.3%).", "anaphor": "a white solid (30 mg, 26.3%)", "gold_antecedents": ["macrocycle C (100 mg, 0.143 mmol)", "p-tolyl isocyanate (19.1 mg, 0.143 mmol)", "triethylamine (78 \u03bcL, 0.574 mmol)"], "preceding_anaphors": []}
{"example_id": "1031-00", "context": "Steps similar to those in example 24 were employed, ruthenium complex 1a (1.2 mg, 0.002 mmol) was used as catalyst.", "anaphor": "catalyst", "gold_antecedents": ["ruthenium complex 1a (1.2 mg, 0.002 mmol)"], "preceding_anaphors": []}
{"example_id": "0080-00", "context": "m. PREPARATION OF (S)-3-(3,5-DIFLUOROPHENYL)-N-((2R,6S,8AS,14AS,20S,23AS)-2,6-DIMETRYL-5,8,14,19,23-PENTAOXOOCTADECAHYDRO-1H,5H,14H,19H-PYRIDO[2,1-I]DIPYRROLO[2,1-C:2',1'-L][1]OXA[4,7,10,13]TETRAAZACYCLOHEXADECIN-20-YL)-2-(3-(4-(TRIFLUOROMETHOXY)PHENYL)UREIDO)PROPANAMIDE (COMPOUND 13). Compound 13 was synthesized from compound C (70 mg, 0.100 mmol), 1-isocyanato-4-(trifluoromethoxy)benzene (24.5 mg, 0.12 mmol) and triethylamine (66 \u03bcL, 0.482 mmol) following the general synthesis method as described herein above. Compound 13.", "anaphor": "Compound 13", "gold_antecedents": ["compound C (70 mg, 0.100 mmol)", "1-isocyanato-4-(trifluoromethoxy)benzene (24.5 mg, 0.12 mmol)", "triethylamine (66 \u03bcL, 0.482 mmol)"], "preceding_anaphors": []}
